InBody Co.,Ltd (KOSDAQ:041830)

Market Cap	396.14B +34.2%
Revenue (ttm)	233.95B +14.4%
Net Income	30.63B -7.6%
EPS	2,422.95 -5.3%
Shares Out	13.34M
PE Ratio	12.26
Forward PE	10.04
Dividend	400.00 (1.39%)
Ex-Dividend Date	Mar 30, 2026

Volume	90,773
Average Volume	29,582
Open	29,000
Previous Close	28,850
Day's Range	28,950 - 30,000
52-Week Range	22,150 - 36,000
Beta	0.48
RSI	51.73
Earnings Date	May 12, 2026

About InBody Co.,Ltd

InBody Co.,Ltd provides body composition analysis solutions worldwide. It offers body composition analyzers, automatic blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 1996
• Employees: 342
• Stock Exchange: KOSDAQ
• Ticker Symbol: 041830

Financial Performance

In 2025, InBody Co.,Ltd's revenue was 233.95 billion, an increase of 14.42% compared to the previous year's 204.46 billion. Earnings were 30.63 billion, a decrease of -7.57%.